Class II
Ongoing
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road,…
Why: Subpotent Drug
- Company
- ACCORD HEALTHCARE, INC.
Raleigh, NC, United States - Reported
- Sep 2, 2026
- Recall started
- Aug 6, 2026
- Where sold
- Nationwide within the United States
- Amount
- N/A
- Full product description
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.
- Lots / codes affected
- Lot #: D2402337, Exp. Date 10/31/2026.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.